BELGRADE, Mont., Nov. 10, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today announced that it will release its financial results for the third quarter ended September 30, 2026, before the start of trading on Monday, November 16, 2026. Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a conference call at 8:30 AM ET on that day.

Conference Details:

Conference Date: Monday, November 16, 2026
Conference Time: 8:30 AM ET
Conference Dial-in: 888-506-0062
International Dial-in: 973-528-0011
Passcode: 429466
Conference Call Name: Xtant Medical Third Quarter 2026 Financial Results
Webcast link: https://www.webcaster5.com/Webcast/Page/3039/54647

Following the live call, a replay will be available on the Company's website, https://xtantmedical.com/, under "Investor info."

About Xtant Medical Holdings, Inc.
Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics serving the chronic and surgical wound care and sports medicine markets, as well as spinal implant systems. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/xtant-medical-to-announce-third-quarter-2026-financial-results-on-november-16-2026-302934835.html

SOURCE Xtant Medical Holdings, Inc.

Investor Relations Contact: Kevin Gardner, LifeSci Advisors, kgardner@lifesciadvisors.com